Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07819812) titled 'Thiotepa-Based Conditioning for Haploidentical Hematopoietic Stem Cell Transplantation in Older Patients With Severe Aplastic Anemia' on Sept. 9.

Study Type: Observational

Primary Sponsor: Peking University People's Hospital

Condition: Severe Aplastic Anemia Hematopoietic Cell Transplant

Intervention: Drug: Thiotepa

Recruitment Status: Not recruiting

Date of First Enrollment: September 20, 2026

Target Sample Size: 20

To know more, visit https://clinicaltrials.gov/study/NCT07819812

Published by HT Digital Content Services with permission from Health Daily Digest....